Autophagy Regulation of Metabolism Is Required for CD8+ T Cell Anti-tumor Immunity
Lindsay DeVorkin,
Nils Pavey,
Gillian Carleton,
Alexandra Comber,
Cally Ho,
Junghyun Lim,
Erin McNamara,
Haochu Huang,
Paul Kim,
Lauren G. Zacharias,
Noboru Mizushima,
Tatsuya Saitoh,
Shizuo Akira,
Wayne Beckham,
Alireza Lorzadeh,
Michelle Moksa,
Qi Cao,
Aditya Murthy,
Martin Hirst,
Ralph J. DeBerardinis,
Julian J. Lum
Affiliations
Lindsay DeVorkin
Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, BC, Canada
Nils Pavey
Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, BC, Canada
Gillian Carleton
Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, BC, Canada; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada
Alexandra Comber
Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, BC, Canada
Cally Ho
Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, BC, Canada; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada
Junghyun Lim
Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA, USA
Erin McNamara
Department of In Vivo Pharmacology, Genentech, Inc., South San Francisco, CA, USA
Haochu Huang
Department of In Vivo Pharmacology, Genentech, Inc., South San Francisco, CA, USA
Paul Kim
Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, BC, Canada; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada
Lauren G. Zacharias
Children’s Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA
Noboru Mizushima
Department of Biochemistry and Molecular Biology, Graduate School and Faculty of Medicine, The University of Tokyo, Tokyo, Japan
Tatsuya Saitoh
Division of Inflammation Biology, Institute for Enzyme Research, Tokushima University, Tokushima, Japan
Shizuo Akira
Department of Host Defense, World Premier International Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan
Wayne Beckham
BC Cancer-Vancouver Island Centre, Medical Physics, Victoria, BC, Canada; Department of Physics and Astronomy, University of Victoria, Victoria, BC, Canada
Alireza Lorzadeh
Department of Microbiology and Immunology and Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada
Michelle Moksa
Department of Microbiology and Immunology and Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada
Qi Cao
Department of Microbiology and Immunology and Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada
Aditya Murthy
Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA, USA
Martin Hirst
Department of Microbiology and Immunology and Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada; Canada’s Michael Smith Genome Science Center, BC Cancer, Vancouver, BC, Canada
Ralph J. DeBerardinis
Children’s Medical Center Research Institute, Department of Pediatrics and McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX, USA
Julian J. Lum
Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, BC, Canada; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada; Corresponding author
Summary: Autophagy is a cell survival process essential for the regulation of immune responses to infections. However, the role of T cell autophagy in anti-tumor immunity is less clear. Here, we demonstrate a cell-autonomous role for autophagy in the regulation of CD8+ T-cell-mediated control of tumors. Mice deficient for the essential autophagy genes Atg5, Atg14, or Atg16L1 display a dramatic impairment in the growth of syngeneic tumors. Moreover, T cells lacking Atg5 have a profound shift to an effector memory phenotype and produce greater amounts of interferon-γ (IFN-γ) and tumor necrosis factor α (TNF-α). Mechanistically, Atg5−/− CD8+ T cells exhibit enhanced glucose metabolism that results in alterations in histone methylation, increases in H3K4me3 density, and transcriptional upregulation of both metabolic and effector target genes. Nonetheless, glucose restriction is sufficient to suppress Atg5-dependent increases in effector function. Thus, autophagy-dependent changes in CD8+ T cell metabolism directly regulate anti-tumor immunity. : DeVorkin et al. show that loss of autophagy enhances CD8+ T-cell-mediated rejection of tumors. Mechanistically, suppression of autophagy shifts T cells to a glycolytic phenotype and causes a reduction in S-adenosylmethionine. As a consequence, autophagy-deficient T cells transcriptionally reprogram immune response genes to an effector memory state. Keywords: autophagy, CD8+ T cells, anti-tumor immunity, glycolysis, lactate, SAM, methylation